ARCHIVES

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979

Fox Chase Forms Network Of Oncologists

February 9, 1996

Proposed DRG Regulations Would Limit Exemptions To Fox Chase, M.D. Anderson; In Effect Oct. 1

September 9, 1983

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Army of Women, caBIG To Collaborate.

August 7, 2009